← Leaderboards
Jae Kyung Lee
University Of Georgia
$2,365,779
Attributed
$2,365,779
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $489.6K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,365,779 · 2
By mechanism
R01$1,936,429 · 1
R21$429,350 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Georgia
Same institution · by research overlap
- Elizabeth A Ottesen$1,884,935
- Arthi Kanthasamy$7,127,865
- Lyndon Michael West$1,068,670
- Mandi M Murph$955,737
Others in their field
Other Emerging Leaders on “Neurons”
- Rui M. Costa · Columbia University Health Sciences$19,333,042
- James Dale Berry · Brigham And Women'S Hospital$16,144,018
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Andrew S Huhn · Johns Hopkins University$14,521,022
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
- Nanthia A Suthana · University Of California Los Angeles$14,167,751
Research focus
NeuronsSurfaceLewy Body DementiaNeuroinflammationNeurotoxicitySchemeInflammationLewy BodiesMicrogliaNerve DegenerationNeuropathologyNeuroprotectionPhenotypePlayAge Related NeurodegenerationBrainInnovationIn VivoAlpha SynucleinLewy Body DiseaseCellsMouse ModelImmuneSynucleinopathy
Grant awards (6)
Elucidating the role of NK cells in Lewy body diseases$334,144
R01 · FY2025 · NS · contact PI
Elucidating the role of NK cells in Lewy body diseases$356,445
R01 · FY2024 · NS · contact PI
Elucidating the role of NK cells in Lewy body diseases$378,821
R01 · FY2023 · NS · contact PI
Elucidating the role of NK cells in Lewy body diseases$377,458
R01 · FY2022 · NS · contact PI
Elucidating the role of NK cells in Lewy body diseases$489,561
R01 · FY2021 · NS · contact PI
Microglial RGS10 as a therapeutic target for Lewy body diseases$429,350
R21 · FY2020 · NS · contact PI